Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus

Transplant Proc. 2011 Jul-Aug;43(6):2455-6. doi: 10.1016/j.transproceed.2011.06.017.

Abstract

Hepatitis C virus infection is a widespread condition, affecting about 170 million people worldwide. It is associated with the progression to cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Therefore, antiviral treatment appears to be recommended for patients infected with HCV. This article reviewed recent evidence on antiviral therapy for HCV-infected patients.

Publication types

  • Review

MeSH terms

  • Antiviral Agents / adverse effects
  • Antiviral Agents / therapeutic use*
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / surgery*
  • Carcinoma, Hepatocellular / virology
  • Hepatitis C / complications
  • Hepatitis C / diagnosis
  • Hepatitis C / drug therapy*
  • Hepatitis C / prevention & control
  • Humans
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / surgery*
  • Liver Cirrhosis / virology
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / surgery*
  • Liver Neoplasms / virology
  • Liver Transplantation* / adverse effects
  • Secondary Prevention
  • Treatment Outcome

Substances

  • Antiviral Agents